Localized amyloidosis of the seminal vesicle: Identification of lactoferrin immunoreactivity in the amyloid material

Pathology International

Volumn 46, Issue 7, 1996, Pages 491-497

  Tsutsumi, Yutaka ^a   Serizawa, Akihiko ^b   Hori, Sadaaki ^b  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY HOSPITAL   (Japan)

Author keywords

gross cystic disease fluid protein 15; lactoferrin; localized amyloidosis; seminal vesicle

Indexed keywords

AMYLOID; AMYLOID P COMPONENT; LACTOFERRIN; MONOCLONAL ANTIBODY; RABBIT ANTISERUM;

AGED; AMYLOIDOSIS; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SEMINAL VESICLE;

EID: 0029774811     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03643.x     Document Type: Article

References (26)

1. Goldman H. Amyloidosis of seminal vesicles and vas deferens: Primary localized cases. Arch. Pathol. 1963; 75: 94-98.
2. Krane RJ, Klugo RC, Olsson CA. Seminal vesicle amyloidosis. Urology 1973; 2: 70-72.
3. Pitkänen P, Westermark P, Cornwell G, Murdoch N. Amyloid of the seminal vesicles: A distinctive and common localized form of senile amyloidosis. Am. J. Pathol. 1983; 110: 64-69.
4. Coyne JD, Kealy WF. Seminal vesicle amyloidosis: Morphological, histochemical and immunohistochemical observations. Histopathology 1993; 22: 173-176.
5. Seidman JD, Shmookler BM, Connolly B, Lack EE. Localized amyloidosis of seminal vesicles: Report of three cases in surgically obtained material. Mod. Pathol. 1989; 2: 671-675.
6. Kaji Y, Sugimura K, Nagaoka S, Ishida T. Amyloid deposition in seminal vesicles mimicking tumor invasion from bladder cancer: MR findings. J. Comput. Assist. Tomogr. 1992; 16: 989-991.
7. Fujihara S, Glenner GG. Primary localized amyloidosis of the genitourinary tract: Immunohistochemical study on eleven cases. Lab. Invest. 1981; 44: 55-60.
8. Cornwell GG, Westermark GT, Pitkanen P, Westermark P. Seminal vesicle amyloid: The first example of exocrine cell origin of an amyloid fibril precursor. J. Pathol. 1992; 167: 297-303.
9. Yanagihara M, Mehregan AH, Mehregan DR. Staining of amyloid with cotton dyes. Arch. Dermatol. 1984; 120: 1184-1185.
10. Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis: A histologic method to assist in differentiating forms of this disease. Lab. Invest. 1977; 36: 274-281.
11. WHO-IUIS Nomenclature Sub-Committee. Nomenclature of amyloid and amyloidosis. Bull. World Health Organ. 1993; 71: 105-112.
12. Aumüller G, Riva A. Morphology and functions of the human seminal vesicle. Andrologia 1992; 24: 183-196.
13. Shin S-R, Iwaki T, Kitamoto T, Tateishi J. Hydrated autoclave pretreatment enhances TAU immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab. Invest. 1991; 64: 693-702.
14. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 1987; 57: 230-236.
15. Sorensen M, Sorensen SPL. The proteins in whey. Compt. Rend Trav. Lab. Carlsberg 1939; 23: 55-99.
16. Metz-Boutigue M-H, Jollès J, Mazurier J et al. Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 1984; 145: 659-676.
17. Wichmann L, Vaalasti A, Vaalasti T, Tuohimaa P. Localization of lactoferrin in the male reproductive tract. Int. J. Androl. 1989; 12: 179-186.
18. Glenner GG. Amyloid deposits and amyloidosis. N. Engl. J. Med. 1980; 302: 1283-1342.
19. Cohen AS, Jones LA. Amyloidosis. Curr. Opin. Rheumatol. 1991; 3: 125-138.
20. Skinner M, Cohen AS, Shirahama T, Cathcart ES. P-component (pentagonal unit) of amyloid: Isolation, characterization, and sequence analysis. J. Lab. Clin. Med. 1974; 84: 604-614.
21. Mason DY, Taylor CR. Distribution of transferrin, ferritin, and lactoferrin in human tissues. J. Clin. Pathol. 1978; 31: 316-327.
22. Haagensen DE Jr, Mazoujian G, Dilley WG, Pederson CE, Kister SJ, Wells SA Jr. Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J. Natl Cancer Inst. 1979; 62: 239-247.
23. Mazoujian G, Pinkus GS, Davis S, Haagensen DE Jr. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast: A marker of apocrine epithelium and breast carcinomas with apocrine features. Am. J. Pathol. 1983; 110: 105-112.
24. Schaller J, Akiyama K, Kimura H, Hess D, Affolter M, Rickli EE. Primary structure of a new actin-binding protein from human seminal plasma. Eur. J. Biochem. 1991; 196: 743-750.
25. Schenkels LC, Schaller J, Walgreen-Weterings E, Schadee-Eestermans IL, Veerman EC, Nieuw-Amerongen AV. Identity of human extra parotid glycoprotein (EP-GP) with secretory actin binding protein (SABP) and its biological properties. Biol. Chem. Hoppe Seyler 1994; 375: 609-615.
26. Autiero M, Cammarota G, Friedlein A et al. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells. Eur. J. Immunol. 1995; 25: 1461-1464.